Achillion reports enrollments in two trials
Achillion reports that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Achillion reports that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the...
GSK’s ViiV secured FDA approval for Dovato after submitting a marketing application with a priority review voucher (PRV) last October. The drug is used to treat...
A new collaboration between UConn Health and the Foundation for Prader-Willi Research will create a centralized, high quality biobank of stem cells to help researchers...
Azitra has been awarded a Phase II Small Business Innovation Research (SBIR) grant (#1853071) of $719,700 from the National Science Foundation (NSF). This grant will support...
Tangen Biosciences was founded in 2013 and is located in Branford, Connecticut. The Company has developed an innovative platform that enables molecular diagnostic technology to...
The Jackson Laboratory (JAX) reports that it has signed a research agreement for up to $4.2 million with Sanofi to identify new targets to treat...
New Haven biopharma Trevi Therapeutics is planning to go public in hopes of raising $86 million to pay for late-stage clinical trials of its drug...
In filings to the U.S. Securities & Exchange Commission between January and March of this year, Connecticut companies reported raising $109 million in the aggregate,...
The University of New Haven has announced that its first-ever comprehensive fundraising campaign has surpassed its original goal of $100 million. The ambitious nine-figure target,...
SpringWorks Therapeutics reports the closing of a $125 million Series B preferred stock financing led by Perceptive Advisors. Proceeds from the financing will be used to...